Mangaluru expat killed in worksite explosion in Qatar

Mysuru/Chamarajanagara, Apr 3: In order to prevent the transmission of Novel Coronavirus though overcrowding, the central jails in Mysuru and Chamarajanagar have begun releasing some of their inmates.

As many as 55 undertrials and convicts were released from Mysuru jail since the last two days, while 18 were released from the prison in Chamarajanagar. The jail inmates had been released on interim bail, for a period of two months.

While the undertrials were facing charges that involved a maximum prison term of seven years, the convicts were facing criminal miscellaneous cases of the family court. Most of the convicts released were prisoners who had not paid the maintenance costs ordered by the family courts in divorce cases.

Bengaluru, Mar 23: The Karnataka government on Monday decided to purchase 1,000 ventilators from medical devices company Skanray Technologies and five lakh Personal Protective Equipment (PPE), amid rising COVID-19 cases.

Health Minister B Sriramulu convened a meeting with officials to review the situation in the wake of the coronavirus outbreak, and with the Mysuru-based firm through a video conference.

"In the meeting, it was decided to buy 1,000 ventilators immediately", the Minister tweeted.

He said the government has already taken steps to buy ten lakh masks, and decided to purchase five lakh PPE.

"The Health Department has been working on a war- footing to halt the spread of the (COVID-19) infections", Sriramulu tweeted.

The Minister appealed to the citizens to strictly follow social distancing.

Six new COVID-19 cases were confirmed in Karnataka on Sunday, taking the total number of infections to the respiratory disease to 26 -- the highest number of positive cases in a single day in the State.

The Karnataka government has announced shutdown of all commercial activities barring essential services in nine districts, where COVID-19 cases have been reported, till March 31.

They are: Bengaluru city, Bengaluru Rural, Mangaluru, Mysuru, Kalaburagi, Dharwad, Chikkaballapura, Kodagu and Belagavi, Home Minister Basavaraj Bommai said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.